巴西状细胞病:当前的管理方式
Aderson da Silva Araújo1, Ana Cristina Silva Pinto2, Clarisse Lopes de Castro Lobo3
1Department of Hematology, Fundação de Hematologia e Hemoterapia de Pernambuco, Recife, Brazil.
状细胞病 (SCD) 是一种遗传性血液疾病,导致红细胞状和血管封闭. 像克里桑利祖马布这样的新疗法提供了希望,特别是在巴西这样的地区.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 状细胞病 (SCD) 是一种遗传性红细胞疾病,由β-环球蛋白基因的特定突变引起.
- 在缺乏氧气的条件下,它导致异常的血红蛋白S聚合,导致红细胞形,血液溶解和血管封闭.
- 血管封闭性危机 (VOC) 是主要的并发症,但SCD可以导致其他严重的健康问题.
研究的目的:
- 审查关于状细胞疾病管理和治疗选择的最新数据.
- 专注于可用的治疗方法,特别是在巴西的背景下.
- 为突出SCD患者的新兴治疗方法.
主要方法:
- 关于状细胞病的最新数据的文献综述.
- 分析治疗选择及其区域可用性.
- 专注于特定的新疗法及其批准状态.
主要成果:
- 状细胞病是一个日益严重的全球健康问题,在美洲和非洲的发病率增加.
- 疾病管理策略因区域资源和社会经济因素而有很大差异.
- 克里桑利祖马布 (Crizanlizumab) 是巴西批准的治疗选择,表明SCD治疗的进展.
结论:
- 全球需要更新关于状细胞疾病治疗的数据.
- 治疗选择的进步,如克里桑利祖马布,对于改善患者的治疗结果至关重要.
- 确保所有SCD患者平等获得新疗法是一个关键的挑战.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
